Non-Hodgkin's Lymphoma Reversal with Dichloroacetate

In June 2007, a 48-year-old male patient, diagnosed with Stage 4 Non-Hodgkin's Follicular Lymphoma (NHL), was treated for 3 months with conventional chemotherapy resulting in a complete remission. Almost one year later tumors returned in the nasopharynx and neck lymph glands. Refusing all sugge...

Descripción completa

Detalles Bibliográficos
Autor principal: Flavin, Dana F.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945664/
https://www.ncbi.nlm.nih.gov/pubmed/20886020
http://dx.doi.org/10.1155/2010/414726
_version_ 1782187236615258112
author Flavin, Dana F.
author_facet Flavin, Dana F.
author_sort Flavin, Dana F.
collection PubMed
description In June 2007, a 48-year-old male patient, diagnosed with Stage 4 Non-Hodgkin's Follicular Lymphoma (NHL), was treated for 3 months with conventional chemotherapy resulting in a complete remission. Almost one year later tumors returned in the nasopharynx and neck lymph glands. Refusing all suggested chemotherapies, the patient began self-administering dichloroacetate (DCA) 900 mg daily with a PET scan showing complete remission four months later. Since his last PET scan, May, 2009, he remains tumor-free from continuous DCA usage.
format Text
id pubmed-2945664
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-29456642010-09-30 Non-Hodgkin's Lymphoma Reversal with Dichloroacetate Flavin, Dana F. J Oncol Case Report In June 2007, a 48-year-old male patient, diagnosed with Stage 4 Non-Hodgkin's Follicular Lymphoma (NHL), was treated for 3 months with conventional chemotherapy resulting in a complete remission. Almost one year later tumors returned in the nasopharynx and neck lymph glands. Refusing all suggested chemotherapies, the patient began self-administering dichloroacetate (DCA) 900 mg daily with a PET scan showing complete remission four months later. Since his last PET scan, May, 2009, he remains tumor-free from continuous DCA usage. Hindawi Publishing Corporation 2010 2010-09-16 /pmc/articles/PMC2945664/ /pubmed/20886020 http://dx.doi.org/10.1155/2010/414726 Text en Copyright © 2010 Dana F. Flavin. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Flavin, Dana F.
Non-Hodgkin's Lymphoma Reversal with Dichloroacetate
title Non-Hodgkin's Lymphoma Reversal with Dichloroacetate
title_full Non-Hodgkin's Lymphoma Reversal with Dichloroacetate
title_fullStr Non-Hodgkin's Lymphoma Reversal with Dichloroacetate
title_full_unstemmed Non-Hodgkin's Lymphoma Reversal with Dichloroacetate
title_short Non-Hodgkin's Lymphoma Reversal with Dichloroacetate
title_sort non-hodgkin's lymphoma reversal with dichloroacetate
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945664/
https://www.ncbi.nlm.nih.gov/pubmed/20886020
http://dx.doi.org/10.1155/2010/414726
work_keys_str_mv AT flavindanaf nonhodgkinslymphomareversalwithdichloroacetate

Ejemplares similares